Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The mixture supplies both essential and non‑essential amino acids directly into the bloodstream. These amino acids serve as building blocks for protein synthesis, replenish nitrogen stores, and support metabolic pathways that are compromised when normal digestion and absorption are unavailable, thereby aiding tissue repair and maintaining cellular function.

The dose of Kabiven is individualized. A qualified prescriber determines the volume and rate of infusion based on the patient’s weight, clinical condition, metabolic needs, and laboratory parameters. No fixed regimen is provided; dosing is adjusted to achieve the desired nutritional goals while monitoring safety.

Safety data for Kabiven in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians must evaluate each case carefully and follow local regulatory guidance.

To order Kabiven, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain handling if needed), and import documentation.

Kabiven offers a comprehensive profile of essential and non‑essential amino acids in a single formulation, matching the amino acid composition recommended for adult parenteral nutrition. Compared with some older solutions that may lack certain essential amino acids, Kabiven provides a balanced mixture designed to reduce the risk of deficiencies and support optimal protein synthesis.

Kabiven must be stored at 2‑8 °C in a refrigerator. Keep the container in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before use, inspect the product for any particulate matter or discoloration and discard if the integrity is compromised.

Kabiven is administered intravenously as a sterile solution for injection. It is typically infused through a central or peripheral venous catheter, either as a continuous infusion or in divided doses, according to the prescriber’s order and the patient’s clinical status. Infusion sets should be compatible and free of air bubbles.

Serious risks include anaphylactic reactions, severe electrolyte disturbances such as hypernatremia, hepatic dysfunction, and thrombophlebitis at the infusion site. Prompt recognition and management of these events are essential. Clinicians should monitor vital signs, laboratory parameters, and infusion site condition throughout therapy.

Kabiven is contraindicated in patients with known hypersensitivity to any of its amino acid components. Caution is advised for individuals with severe renal or hepatic impairment, uncontrolled electrolyte abnormalities, or those receiving incompatible intravenous solutions. Clinical judgment should guide use in each specific situation.